Daily One – Johnson & Johnson potions: his talc had a carcinogen and the company knew it


Shares Johnson & Johnson, a giant of hygiene products and pharmaceuticals, fell to 10 percent on Wall Street on Friday. The derogation came after Reuters reported that the company had known for 40 years that its powder powder was contaminated with asbestos, which the company denied on several occasions. The one who was his golden egg hen, who has already made thousands of requests for ovarian cancer, returns to hit a company that has wiped out forty thousand million market capitalization this time.

Agency information based on company confidential documents and reports state that since 1971, in their products, they have been aware of the presence of small quantities of asbestos (carcinogens).

The multinational group had several collective tests of women claiming to have been victims of carcinogens. It also collects about 10,000 lawsuits relating to Johnson's baby product. In the midst of legal battles and the publication of the Reuters report, the company has seen the biggest fall in the stock market over the past 16 years.

Reuters also reports that the company commissioned and paid for studies conducted in the franchise for children's powder. "Any suggestion that Johnson & Johnson knew or concealed information about the safety of talcum powder is incorrect," the company replied.

A few months ago, the highest healthcare facility in the United States (FDA, in its acronyms in English) carried out a study of product samples that did not detect the presence of asbestos. However, this did not stop the jury in Saint Louis, Missouri, to order the company in July to pay $ 4.96 billion to women and to 22 families who responded that after the use of the baby product they were picked up. The company complained about the decision.

Last year, a court in Los Angeles condemned a multinational corporation to pay $ 417 million to a woman who has developed ovarian cancer for many years after using powdery powder. It was asserted that Johnson & Johnson did not adequately warn of the risk of cancer associated with the use of products. This decision was successfully contested by the company. "Science has been imposed," said Bart Williams, a lawyer for the pharmaceutical giant. On Wall Street this Friday overcame investors' skepticism.

Source: Country


Source link